PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of archdischArchives of Disease in ChildhoodVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
 
Arch Dis Child. 1993 May; 68(5): 653–657.
PMCID: PMC1029335

Liver cirrhosis in cystic fibrosis--therapeutic implications and long term follow up.

Abstract

Experience gained from liver studies in 450 patients with cystic fibrosis, seen in a 38 year period from 1964 to 1992, is surveyed. Of these, 31 (7%) showed findings that indicated multilobular cirrhosis. There was a slight but not significant male predominance: 19 males against 12 females. Liver disease had its onset during childhood in most cases. The natural course of liver disease and of cirrhosis is protracted. All patients were routinely evaluated by way of: (i) clinical examination, (ii) biochemical studies and specifically estimation of transaminases and gamma glutamyltransferase, and (iii) liver imaging, ultrasonography, and computed tomography. The study aimed to detect early liver disease, that is multilobular cirrhosis and its complications, with a view to optimal introduction of treatment with ursodeoxycholic acid as this drug shows promise for preventing or stabilising the cirrhotic process. Effects of surgical treatment on portal hypertension are surveyed. These include portacaval shunting, partial splenectomy (considered the procedure of choice), liver transplant in the event of liver failure, or a triple transplant (liver, lungs, and heart) if necessary. One triple transplant was successfully performed in a boy of 10 years with a 2 year follow up.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.0M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • BLANC WA, DI SANT'AGNESE PA. A distinctive type of biliary cirrhosis of the liver associated with cystic fibrosis of the pancreas; recognition through signs of portal hypertension. Pediatrics. 1956 Sep;18(3):387–409. [PubMed]
  • Feigelson J, Pecau Y, Cathelineau L, Navarro J. Additional data on hepatic function tests in cystic fibrosis. Acta Paediatr Scand. 1975 Mar;64(2):337–344. [PubMed]
  • Feigelson J, Pecau Y, Perez R. Liver scanning and liver function in cystic fibrosis. Acta Paediatr Scand. 1972 May;61(3):337–342. [PubMed]
  • Goodchild MC, Banks AJ, Drolc Z, Anderson CM. Liver scans in cystic fibrosis. Arch Dis Child. 1975 Oct;50(10):813–815. [PMC free article] [PubMed]
  • Wilson-Sharp RC, Irving HC, Brown RC, Chalmers DM, Littlewood JM. Ultrasonography of the pancreas, liver, and biliary system in cystic fibrosis. Arch Dis Child. 1984 Oct;59(10):923–926. [PMC free article] [PubMed]
  • Cunningham DG, Churchill RJ, Reynes CJ. Computed tomography in the evaluation of liver disease in cystic fibrosis patients. J Comput Assist Tomogr. 1980 Apr;4(2):151–154. [PubMed]
  • Schuster SR, Shwachman H, Toyama WM, Rubino A, Taik-Khaw K. The management of portal hypertension in cystic fibrosis. J Pediatr Surg. 1977 Apr;12(2):201–206. [PubMed]
  • Scott-Jupp R, Lama M, Tanner MS. Prevalence of liver disease in cystic fibrosis. Arch Dis Child. 1991 Jun;66(6):698–701. [PMC free article] [PubMed]
  • Maurage C, Lenaerts C, Weber A, Brochu P, Yousef I, Roy CC. Meconium ileus and its equivalent as a risk factor for the development of cirrhosis: an autopsy study in cystic fibrosis. J Pediatr Gastroenterol Nutr. 1989 Jul;9(1):17–20. [PubMed]
  • Nagel RA, Westaby D, Javaid A, Kavani J, Meire HB, Lombard MG, Wise A, Williams R, Hodson ME. Liver disease and bile duct abnormalities in adults with cystic fibrosis. Lancet. 1989 Dec 16;2(8677):1422–1425. [PubMed]
  • Colombo C, Setchell KD, Podda M, Crosignani A, Roda A, Curcio L, Ronchi M, Giunta A. Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis. J Pediatr. 1990 Sep;117(3):482–489. [PubMed]
  • Louis D, Chazalette JP. L'hypertension portale dans la mucoviscidose. Intérêt de la splénectomie partielle. Pathol Biol (Paris) 1991 Jun;39(6):629–630. [PubMed]
  • Psacharopoulos HT, Howard ER, Portmann B, Mowat AP, Williams R. Hepatic complications of cystic fibrosis. Lancet. 1981 Jul 11;2(8237):78–80. [PubMed]
  • Mieli-Vergani G, Psacharopoulos HT, Nicholson AM, Eddleston AL, Mowat AP, Williams R. Immune responses to liver membrane antigens in patients with cystic fibrosis and liver disease. Arch Dis Child. 1980 Sep;55(9):696–701. [PMC free article] [PubMed]
  • PORTA EA, STEIN AA, PATTERSON P. ULTRASTRUCTURAL CHANGES OF THE PANCREAS AND LIVER IN CYSTIC FIBROSIS. Am J Clin Pathol. 1964 Nov;42:451–465. [PubMed]
  • Sinaasappel M. Hepatobiliary pathology in patients with cystic fibrosis. Acta Paediatr Scand Suppl. 1989;363:45–51. [PubMed]
  • Starzl TE, Demetris AJ, Van Thiel D. Liver transplantation (1). N Engl J Med. 1989 Oct 12;321(15):1014–1022. [PubMed]
  • Starzl TE, Demetris AJ, Van Thiel D. Liver transplantation (2). N Engl J Med. 1989 Oct 19;321(16):1092–1099. [PubMed]
  • Whitington PF, Balistreri WF. Liver transplantation in pediatrics: indications, contraindications, and pretransplant management. J Pediatr. 1991 Feb;118(2):169–177. [PubMed]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group